Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice

British Medical Journal

Volumn 328, Issue 7437, 2004, Pages 434-437

  Jenkins, Christine ^a,c   Costello, John ^b   Hodge, Linda ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; ANAMNESIS; ASPIRIN INDUCED DISEASE; ASTHMA; BIOSIS; CHILD; CLINICAL PRACTICE; CROSS ALLERGY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG INTERACTION; EMBASE; HUMAN; IATROGENIC DISEASE; INCIDENCE; INFORMATION RETRIEVAL; METHODOLOGY; OUTCOMES RESEARCH; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SCISEARCH; STATISTICAL ANALYSIS; UTILIZATION REVIEW;

EID: 1342280445     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.328.7437.434     Document Type: Review

References (12)

1. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977;60:276-84.
2. Stevenson DD. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1984;74:617-22.
3. Chandrasekharan IW, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Nat Acad Sci USA 2002;99:13926-31.
4. Schwab JM, Schluesener HJ, Laufer S. COX-3: just another COX or the solitary elusive target of paracetamol? Lancet 2003;361:981-2.
5. Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108:47-51.
6. Kwoh CK, Feinstein AR. Rates of sensitivity reactions to aspirin: problems in interpreting the data. Clin Pharmacol Ther 1986;40:494-505.
7. Levy S, Volans G. The use of analgesics in patients with asthma. Drug Safety 2001;24:829-41.
8. Vally H, Taylor ML, Thompson PJ. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002;57:569-74.
9. Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000;15:863-9.
10. Szczeklik A, Sanak M. Molecular mechanisms in aspirin-induced asthma. Allergy Clin Immunol Int 2000;12:171-6.
11. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. Eur Respir J 2000;16:432-6.
12. Settipane RA, Schrank PJ, Simon RA, Mathison DA, Christiansen SC, Stevenson DD. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol 1995;96:480-5. (Accepted 14 November 2003)